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Abstract
Background: Chlamydial bacteria are obligate intracellular pathogens containing a cysteine-rich
porin (Major Outer Membrane Protein, MOMP) with important structural and, in many species,
immunity-related roles. MOMP forms extensive disulphide bonds with other chlamydial proteins,
and is difficult to purify. Leaderless, recombinant MOMPs expressed in E. coli have yet to be
refolded from inclusion bodies, and although leadered MOMP can be expressed in E. coli cells, it
often misfolds and aggregates. We aimed to improve the surface expression of correctly folded
MOMP to investigate the membrane topology of the protein, and provide a system to display native
and modified MOMP epitopes.
Results: C. trachomatis MOMP was expressed on the surface of E. coli cells (including "porin
knockout" cells) after optimizing leader sequence, temperature and medium composition, and the
protein was functionally reconstituted at the single-channel level to confirm it was folded correctly.
Recombinant MOMP formed oligomers even in the absence of its 9 cysteine residues, and the
unmodified protein also formed inter- and intra-subunit disulphide bonds. Its topology was
modeled as a (16-stranded) β-barrel, and specific structural predictions were tested by removing
each of the four putative surface-exposed loops corresponding to highly immunogenic variable
sequence (VS) domains, and one or two of the putative transmembrane strands. The deletion of
predicted external loops did not prevent folding and incorporation of MOMP into the E. coli outer
membrane, in contrast to the removal of predicted transmembrane strands.
Conclusions: C. trachomatis MOMP was functionally expressed on the surface of E. coli cells under
newly optimized conditions. Tests of its predicted membrane topology were consistent with β-
barrel oligomers in which major immunogenic regions are displayed on surface-exposed loops.
Functional surface expression, coupled with improved understanding of MOMP's topology, could
provide modified antigens for immunological studies and vaccination, including live subunit vaccines,
and might be useful to co-express MOMP with other chlamydial membrane proteins.
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Background
Every Gram-negative bacterium in the order Chlamydiales
is an obligate intracellular pathogen [1]. The organisms
are dimorphic, and alternate between free-living, infec-
tious "elementary bodies" (EBs) endocytosed by mucosal
cells into vesicular inclusions, and metabolically active,
intracellular "reticulate bodies" (RBs). RBs replicate and
redifferentiate into EBs before being released to infect
neighboring cells, and infections (including Chlamydia
muridarum pneumonitis, an important animal model) are
often complicated by a damaging immune response and
chronic inflammation. Human genital C. trachomatis
infections are associated with ectopic pregnancy and infer-
tility, and serovars that target ocular membranes can lead
to trachoma and blindness. Chlamydophila pneumoniae
(Ch. pneumoniae) causes pneumonia in the elderly, and
colonization of the placenta by Ch. abortus causes abor-
tion in ewes (and, occasionally, in women).
Uniquely among bacteria, the chlamydial outer mem-
brane (OM) is reinforced by a network of disulphide
bonds [2]. Treatment of EBs with Sarkosyl produces
"chlamydial OM complexes" (COMCs) [3] containing
three relatively detergent-resistant, cysteine-rich proteins:
the Major Outer Membrane Protein (MOMP), encoded by
ompA, and OmcB and OmcA, encoded by omp2 and omp3,
respectively. MOMP (~40 kDa) is expressed in both EBs
and RBs [4]. It contains extensive β-sheet secondary struc-
ture and forms large pores [5,6], similar to β-barrel porins
found in other outer bacterial membranes (e.g. E. coli
OmpF). The MOMPs encoded by different C. trachomatis
serovars share five well-conserved regions and four "vari-
able sequence" (VS) domains [7,8]. C. trachomatis VS
domains, and homologous regions in MOMPs from other
species, could correspond to cysteine-rich surface-exposed
loops in a porin β-barrel, and EB MOMP is oxidised and
highly cross-linked, making the OM very stable. RBs in
contrast are osmotically active with reduced, mainly mon-
omeric, MOMP [9]. MOMP's pore-forming ability is
enhanced by reduction [5], compatible with a link
between reversible disulphide bond formation and the
developmental stage of the bacteria. Supporting this idea,
DTT-reduced EBs tend to resemble RBs [5], and native
MOMP is monomeric when solubilised in SDS under
reducing conditions, but forms monomers, dimers, trim-
ers, tetramers and even larger complexes [e.g. [6,10,11]]
under oxidising conditions.
C. trachomatis MOMP is highly immunogenic. Antibodies
to the protein neutralised EB infectivity [12], and triggered
approaches to generate MOMP-based vaccines [e.g.
[13,14]]. However, as implied earlier, the immunopathol-
ogy of chlamydial infections is complicated [15], with TH1
type immune responses as well as specific antibodies (TH2
responses). MOMP is not equally immunogenic in all spp.,
and it also stimulates T-cell division, including CD4+ and
CD8+ T-cells, enhancing IFN-γ secretion [16]. C. trachom-
atis MOMP will probably need to be modified to form a
safe and effective subunit vaccine, emphasizing the
importance of understanding its structure in more detail.
OmcA and OmcB (the other main components of the
COMC) are present as approximately 1 OmcB:2 OmcA:5
MOMP [17]. Ch. psittaci (formerly known as C. psittaci)
OmcA is a 9 kDa lipid-anchored protein with 14 cysteine
residues [18], while OmcB (60 kDa) contains 37 cysteines
[19]. The Omc proteins may not be integral membrane
proteins. Reduced OmcB is water-soluble, and although
OmcA remains membrane-associated, it can be readily
solubilised when reduced [20], and neither protein was
detected on the surface of intact EBs by immunogold labe-
ling [21]. Regardless of their membrane association,
OmcB appears to be extensively cross-linked in the peri-
plasm of EBs, forming disulphide bonds with both
MOMP and OmcA. Appropriately, both Omc proteins are
expressed late in the developmental cycle (from a bicis-
tronic operon), as RBs are reorganized into EBs [22], con-
sistent with the idea that RB MOMP is functional and
exchanges nutrients and other factors (possibly including
signaling molecules) with the host cell. Extensive disul-
phide cross-linking in EBs may inactivate the porin, and
prevent expansion of the growing bacterial cell wall.
Although MOMP is of major biological and clinical inter-
est, chlamydia only grow in eukaryotic cells, and MOMP
is difficult to isolate and purify because it can aggregate
when oxidized, or interact with other cysteine-rich
chlamydial proteins. As a result, many groups have
expressed recombinant MOMP in E. coli using full-length
ompA genes that include the signal sequence to target the
translated protein to the OM. Although leadered MOMP
can be expressed in a heterologous system [23-25], this
approach has proved to be highly problematic, because
the protein tends to misfold and aggregate. Koehler et al.
[26] demonstrated surface-exposure, but with a dramatic
reduction in cell viability, including OM disruption and
substantial cell lysis (i.e. unincorporated, periplasmic
MOMP may have been exposed). Jones et al. [27] co-
reconstituted recombinant MOMP with endogenous E.
coli porins, and showed altered solute permeabilities in
liposome-swelling assays. Although attributed to novel
porin activity, this could have reflected modification of
endogenous porins. Wyllie et al. [28] pursued an alterna-
tive approach with truncated versions of Ch. abortus and
Ch. pneumoniae MOMP, and obtained small amounts of
folded proteins without prior denaturation and refolding,
sufficient for incorporation into planar bilayers and sin-
gle-channel recording. Other expression systems, pio-
neered because of their potential for vaccine delivery,BMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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include mammalian COS cells [29] and Vibrio cholerae
[30].
PorB (37 K), a second putative porin, is also surface-
exposed in chlamydia [31]. Recombinant PorB specifi-
cally transported dicarboxylates in liposome-swelling
assays [32], although. it was used with a C-terminal His
tag. The terminal residues of porins normally meet to
complete a transmembrane β-strand, and may even be
linked by a salt bridge. Being integral to the protein fold,
additional terminal residues might affect the conforma-
tion and, therefore, the specific function of a porin. We
expressed PorB as well as MOMP to help determine the
factors affecting chlamydial porin expression, but because
of these theoretical concerns concerning porin folding
and function, we avoided tagged proteins in the present
study, and built on previous work with leadered
constructs.
We developed improved conditions for the surface expres-
sion of MOMP in E. coli cells, and demonstrated unambig-
uously by single-channel recording that recombinant C.
trachomatis MOMP folded and formed a functional pro-
tein in the absence of many endogenous porins. We
showed that MOMP can insert into the outer membrane
of E. coli cells and form SDS-sensitive oligomers in the
absence of cysteine residues, and generated a "working
model" of the topology of MOMP to provide structural
hypotheses that could be tested by engineering the recom-
binant protein.
Results
Optimised MOMP expression in E. coli cells
Our first objective was to obtain properly folded recom-
binant chlamydial porins in the outer membranes of E.
coli  cells. Building on previous work (e.g. [26]),
BL21(DE3) cells were transformed with pET-ompA or pET-
porB constructs, and expression was induced by 1 mM
IPTG at 37°C after growth to an OD600 of 0.6. Compared
to the expression of non-leadered proteins (which accu-
mulate in cytoplasmic inclusion bodies), cells expressing
leadered porins must transport the immature full-length
porin across the inner membrane, cleave the leader
sequence in the periplasmic space, and fold and insert the
mature protein into the OM. Expression of mature, lead-
erless C. trachomatis MOMP did not inhibit growth com-
pared to non-transformed cells, in contrast to substantial
inhibition with full length MOMP (Fig. 1A). To investi-
gate whether different leader sequences could improve
processing, C. trachomatis MOMP was expressed with the
OmpT leader rather than its native leader. Initial growth
rates were comparable to those shown by non-trans-
formed cells, and similar to cells expressing mature
MOMP (i.e. MOMP without a leader sequence), although
the cultures again showed a reduced final cell density.
We next investigated the expression of MOMPs from other
chlamydial spp. to determine whether the observed effects
were specific to C. trachomatis MOMP, and we also
expressed C. muridarum PorB to exclude a universal prob-
lem with the expression of all putative chlamydial porins
in E. coli. The constructs had different effects on cell viabil-
ity (Fig. 1B). Bacteria expressing C. muridarum MOMP
Effects of leader sequences on the growth of E. coli BL21 cells  expressing chlamydial porins Figure 1
Effects of leader sequences on the growth of E. coli 
BL21 cells expressing chlamydial porins. A. Moderate 
inhibition of bacterial (BL21) growth during expression of C. 
trachomatis MOMP containing native (nL-TR) and OmpT (oT-
TR) leaders, contrasting with lack of significant inhibition dur-
ing expression of mature, leaderless C. trachomatis MOMP 
(TR). B. Slight inhibition of bacterial growth during expres-
sion of C. muridarum MOMP with its native leader (nL-MU, 
compare to BL21 in A), contrasting with strong inhibition 
when Ch. abortus MOMP is expressed with its native leader 
(nL-AB). Cell growth is markedly reduced with both native-
leadered PorB (nL-PB) and OmpT-leadered PorB (oT-PB). 
Note the "recovery" as non-resistant organisms overgrow in 
β-lactamase-containing cultures (see text). Measurements 
are means ± SEM (n = 4 independent experiments).
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grew more slowly than bacteria expressing C. trachomatis
MOMP, although the bacteria continued to grow slowly
throughout the entire period of induction. The growth of
bacteria expressing Ch. abortus MOMP or C. muridarum
PorB was markedly reduced, and the density decreased
after 30 min. The "recovery" at later stages reflected multi-
plication of non-expressing cells in the presence of β-
lactamase released from dead or dying cells (growth
ceased on fresh Ampicillin plates, data not shown). We
then changed the leader sequences. The growth of cells
expressing C. trachomatis MOMP and C. muridarum PorB
was improved by replacing the native chlamydial leader
with the E. coli OmpT leader, and the decrease in optical
density occurred later in the induction and continued
more slowly. In contrast, no significant improvement was
seen when Ch. abortus MOMP was expressed with the
OmpT leader (data not shown).
We also expressed full-length constructs in E. coli
BL21(DE3)omp8 cells lacking expression of the endog-
enous porins LamB, OmpA, OmpC and OmpF [34]. Tox-
icity was more pronounced than in unmodified BL21
cells, and after establishing conditions for detergent
extraction of recombinant MOMP (Additional Data File
#1), expression conditions were further optimised to
improve the yield of processed, recombinant protein.
Native and OmpT-leadered C. trachomatis MOMP con-
structs were induced rapidly at 37°C with 1 mM IPTG or
slowly at 16°C with 0.1 mM IPTG (Fig. 2). At 37°C both
versions of MOMP were expressed, and by 4 hours about
half the protein was processed, as shown by the doublet
band of OM-associated MOMP with and without its sig-
nal sequence (Fig. 2). The ~2 kDa difference between the
cleaved and non-cleaved protein bands (38 kDa and 40
kDa, respectively), is similar to the difference seen when
leadered versions of E. coli OmpF are expressed). There
was a slight decrease in total protein when MOMP was
expressed with its native leader at 16°C, but the propor-
tion of processed protein was unchanged. Although pro-
tein decreased following slow induction of MOMP
containing the OmpT leader, most of the protein was
processed. Based on these observations, slow induction of
native-leadered MOMP was carried out in different
growth media for prolonged periods. After growing for 6
hours, cultures in LB medium plateaued at an OD600
~0.85, after which the cells began to lyse. In contrast, cells
cultured in more supportive SOC medium continued to
grow steadily, and began to plateau about 12 hours after
induction (Additional Data File #2).
Processing and surface expression of mutagenised and 
engineered MOMPs
Given the known difficulties associated with protein mis-
folding and aggregation (e.g. [23-26]), a particular prob-
lem for chlamydial MOMPs compared to other bacterial
porins, our next objective was to determine whether
MOMP was actually inserted into the E. coli outer mem-
brane. Although recombinant MOMP was associated with
the OM fraction following subcellular fractionation, the
observation that its leader sequence was not always
cleaved (Fig. 2) suggested that some leadered protein co-
fractionated with OMs, possibly as a peripheral mem-
brane protein. This raised the possibility that even cleaved
recombinant proteins might not be fully integrated into
the OM. To determine whether processed MOMP was
actually inserted into (and across) the OM, we carried out
whole cell immunoblots to probe for the presence of
MOMP epitopes on the surface of intact E. coli BL21 cells.
Because of the importance of reduced temperature (Fig.
2), we carried out inductions for whole cell immunoblot-
ting at 37°C, 16°C and an intermediate temperature of
25°C. MOMP was incorporated into the OM at both
25°C and 16°C, when induced in the presence of either 1
mM or 0.1 mM IPTG, respectively. Expression and
processing were more rapid at 25°C, and because the pres-
ence of some unprocessed protein was irrelevant in this
experiment, we induced the cells at 25°C for 2 hrs. Non-
transformed BL21 cells, or cells transformed with an
empty plasmid, and BL21 cells transformed with con-
structs encoding mature, leaderless C. trachomatis MOMP,
or with OmpT-leadered MOMP and native leadered-
MOMP, were applied to a nitrocellulose membrane
Expression and processing of C. trachomatis MOMP in  BL21omp8 cells Figure 2
Expression and processing of C. trachomatis MOMP in 
BL21omp8 cells. Coomassie-stained 12% (w/v) SDS-PAGE 
of OM proteins extracted using 1%(w/v) OG (10 µg protein 
per lane) from cells induced for 4 hrs in LB medium, showing 
dependence of C. trachomatis MOMP expression and 
processing on temperature and leader sequence. Cells incu-
bated at 16°C and 37°C were induced with 0.1 mM IPTG and 
1 mM IPTG, respectively. omp8: non-transformed omp8 
cells; oT-TR: cells expressing C. trachomatis MOMP with the 
OmpT leader; nL-TR: cells expressing C. trachomatis MOMP 
with its native leader.
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(avoiding methanol-activated PVDF, and the risk of OM
permeabilisation and exposure of periplasmic MOMP),
and probed with anti-MOMP pAb (Fig. 3A).
The absence of a signal from control cells and cells
expressing MOMP in its non-leadered, mature form con-
firmed the incubation and blotting conditions did not
cause cell lysis and expose unincorporated protein. Both
OmpT- and native-leadered MOMP were detected on the
cell surface (Fig. 3A, whole cell blots), confirming they
were inserted into the OM. Unfortunately, BL21omp8
cells were too fragile to survive the same blotting proce-
dure. SDS-PAGE analysis of OG-solubilised OM fractions
(Fig. 3A, middle panel) confirmed MOMP expression and
processing, although parallel immunoblots (Fig. 3A,
lower panel) showed faint additional bands of ~40 kDa
for the leadered proteins, indicating that processing was
incomplete, as expected. Parallel immunofluorescence
data (Fig. 3B) showed MOMP was confined to cytoplas-
mic inclusion bodies containing the mature protein when
the appropriate cells were fixed and permeabilised before
staining (Fig. 3B, panel b). As expected, staining was
absent when the antibody was applied before permeabili-
sation (data not shown). However, OM staining was seen
for MOMP expressed with both the OmpT leader and the
native leader (panels c and e, respectively). When these
cells were permeabilised before staining (panels d and f,
respectively), immunoreactive protein was also noted
internally, as expected (e.g. Fig. 3A, lower panel),
although reduced or absent in BL21omp8 cells induced
for 12 hrs at 16°C in more supportive SOC medium (Fig.
3B, inset in panel d).
We concluded that MOMP constructs encoding appropri-
ate leaders could be expressed in E. coli, cross the inner
membrane, and be processed in the periplasm. Further-
more, under modified incubation and induction condi-
tions (especially at reduced temperatures, and in the
relatively supportive medium SOC), MOMP could be
folded and incorporated into the outer membrane.
Membrane topology of MOMP
Having confirmed that C. trachomatis MOMP was inserted
into the OM of E. coli cells, we set out to investigate how
the protein was organized in the membrane. While noting
that predictive algorithms must always be deployed with
care, and with reference to established findings for a given
protein, we first analyzed MOMP's primary sequence for
membrane crossings using a neural network trained with
OM proteins of known structure [36]. The analysis (Fig.
4A) showed 16 membrane crossings. As expected, the VS
domains of C. trachomatis MOMP generally corresponded
to regions of the protein predicted to be extracellular.
Insertion of MOMP into the E. coli outer membrane Figure 3
Insertion of MOMP into the E. coli outer membrane. 
A. Recombinant C. trachomatis MOMP was expressed for 2 
hrs at 25°C from constructs encoding either no leader 
(mature), the OmpT (oT) leader, or the native (n) leader, 
and immunodetected on the surface of intact BL21 cells 
(upper panel) using a specific anti-MOMP polyclonal Ab. 
Non-expressing BL21 cells (BL) show no signal, and mature, 
leaderless MOMP does not reach the cell surface. The middle 
and lower panels show, respectively, SDS-PAGE and immu-
noblot analyses of the corresponding recombinant proteins 
under these conditions (prepared as in Fig. 2). Note the pres-
ence of some unprocessed protein, revealed by the immuno-
blots of leadered protein expression. Representative of 3 
similar experiments. B. Immunofluorescence confocal micro-
scopy (panels b–f), with examples of unstained cells (panel a); 
cells permeabilised and stained after expressing mature, non-
leadered MOMP (panel b); cells expressing OmpT-leadered 
MOMP stained before (panel c) and after permeabilisation 
(panel d, with inset permeabilised omp8 cell after 12 hrs 
induction at 16°C); cells expressing native-leadered MOMP 
under corresponding conditions (panels e and f, respec-
tively). The scale bar (panel c) is 3 µm, and the arrow points 
out membrane staining. Representative of 3 similar 
experiments.
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We then reanalyzed the sequence using two β-strand pre-
diction programs (Fig. 4B). The combined analysis
revealed a total of 16 strands, corresponding numerically
to the initial "membrane crossing" prediction (which
does not on its own appear to be sufficient to identify the
specific extramembrane domains). We discarded the
strand coinciding with VS1 in B2TMPRED (see Methods)
because VS domains are likely to be extracellular loops,
and inserted an extra strand between G210 and S218 to
bring the chain back across the membrane, so that all 4 VS
domains remained external. Minor adjustments were
made to accommodate known constraints on β-strand
organization and porin structures [39,40]. The final work-
ing model (Fig. 5) provided testable hypotheses concern-
ing the pattern of transmembrane folding. All the cysteine
residues were predicted to be accessible for inter- or
intrasubunit disulphide bond formation or cross-linking
with other proteins. Most were predicted to be external,
but two were periplasmic. Although one thiol group was
in a predicted transmembrane domain, it faced the central
water-filled pore rather than the lipid bilayer, where it
could potentially interact with a cysteine thiol on a pore-
confined loop.
We designed four C. trachomatis MOMP constructs (with
intact cysteines and native leaders, to correspond exactly
in these respects to the "wild-type" protein) in which sub-
stantial regions of VS domains 1, 2, 3 or 4 (shown in Fig.
6A) were deleted, to test the prediction that these domains
are surface-exposed loops that can be shortened without
compromising the main β-barrel fold and membrane
insertion. The region removed from VS1 was G63 to Y87;
from VS2, E141 to F156; from VS3, Y220 to G238; and
from VS4, D278 to T318. Our strategy (see Methods)
resulted in some mutations. Most were conservative
changes (M62T in VS1, T239V in VS3 and A277V in VS4),
apart from G219D in VS3. However, our topology predic-
tion placed this residue in an external loop, where the
additional charge was unlikely to be significant. We also
generated another pair of constructs with deletions of
either one or two of the predicted β-strands between VS
domain 1 and VS domain 2 (summarized in Fig. 6B–C),
in an attempt to disrupt the formation of OM-inserting β-
barrels. These constructs were designated: ∆β5, with
removal of E95 to F111 (with no residue changes) and
∆β5,6, with removal of F97 to A129 (with 2 changes,
E95D and M96V).
Before expressing the cDNAs encoding putative loop or
strand deletions, we re-examined the expression and OM
insertion of full-length C. trachomatis MOMP using a con-
struct in which all 9 cysteine residues (Fig. 4A, circles; Fig.
5, shaded residues) were replaced by alanine. The results
(Fig. 7A) were similar to those for the non-mutagenised
protein, showing that folding and membrane insertion
could proceed without cysteine residues and without the
controlled formation of disulphide bonds (as it may do in
RBs). We then expressed each of the "loop-deleted"
MOMP proteins in BL21 cells. All four were detected on
the cell surface (Fig. 7B), demonstrating incorporation
into the OM. In contrast, recombinant proteins expressed
from constructs with putative β-stand deletions were not
detectable on the surface of E. coli cells (Fig. 7). We con-
sidered the unusual possibility that all the epitopes in the
"strand-deleted" proteins might have been unreactive in
the E. coli membrane, due to masking or oligomerisation,
but suspension of the cells in Tris (rather than phosphate)
buffer (100 mM NaCl, 50 mM Tris-HCl, pH 7.4), or the
addition of 2 mM EDTA, failed to "unmask" any immu-
noreactivity (Additional Data File #3).
MOMP forms oligomers in the E. coli outer membrane
Native MOMPs are difficult to purify free from other
chlamydial proteins [6], precluding firm conclusions
about native subunit structure, especially in the absence of
protein (cysteine) oxidation. In preliminary investiga-
tions of the subunit organisation of recombinant MOMP,
we noted that the recombinant protein did not form SDS-
resistant oligomers (Additional Data File #4). However,
unlike trimeric E. coli porins [40], oligomers of isolated
MOMP, away from their normal membrane environment
[6], may be unstable in the presence of SDS, so we sub-
jected detergent-solubilised OM extracts to large-scale
Membrane topology and secondary structure predictions for  C. trachomatis MOMP Figure 4
Membrane topology and secondary structure predic-
tions for C. trachomatis MOMP. A. "Membrane crossing" 
prediction. Surface-exposed VS domains and cysteine resi-
dues are indicated by boxes and circles, respectively. A 
"complete membrane crossing" corresponds to a (contigu-
ous) region of the plot that crosses both dotted lines in 
sequence, where the dotted lines represent the internal 
(periplasmic) and external borders of the outer membrane 
(in Z units). B. Two independent β-strand predictions, 
TMBETA [38] (upper line) and B2TMPRED [37] (below). The 
strands are boxed. The residue numbers refer to the mature 
(processed) protein.BMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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non-denaturing GE chromatography in milder detergents.
For these and all subsequent experiments, MOMP was
expressed in BL21omp8 cells with the OmpT leader (in
SOC medium, at 16°C), to exclude heterooligomers con-
taining endogenous E. coli porins, and minimize unin-
serted periplasmic protein, respectively.
We carried out GE chromatography in LDAO or Zwitter-
gent 3–14 (having previously noted these to be cheaper
but equally effective detergents to replace OG, Additional
Data File #1), with excess (5 mM) DTT in the presence of
MOMP cysteine residues (calibrating the column in the
presence of detergent). Under these conditions, MOMP
appeared to form oligomers containing 2–4 subunits,
although some recombinant MOMP always formed
higher-order oligomers (Fig. 8). Similar results were
obtained after repeating each experiment at least twice.
The apparent subunit stoichiometry of recombinant
MOMP depended on the detergent, with putative dimers
in LDAO, and trimers or tetramers in Zwittergent 3–14,
depending on the presence or absence of cysteine resi-
dues, respectively. However, it should be emphasized that
only the major quaternary species was identified in each
case. The presence of oligomers in LDAO or Zwittergent
Model of C. trachomatis MOMP Figure 5
Model of C. trachomatis MOMP. The MOMP β-barrel is broken apart at the putative N-C salt bridge in β-strand 16 to dis-
play the protein in a 2-D projection. Residues in the transmembrane strands are boxed, with a bold border to indicate side 
chains facing the bilayer. External loops (including constituent VS domains) are labeled, and cysteine residues are shaded.
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3–14 contrasted with the absence of SDS-resistant oli-
gomers during SDS-PAGE, and oligomer formation even
in the absence of cysteine residues argued against an
essential role for disulphide bonds.
We also investigated the subunit organization of MOMP
by covalent cross-linking following expression and inser-
tion into BL21omp8 OMs, by removing DTT to allow in
situ cysteine oxidation by dissolved oxygen. OM proteins
were then incubated in SDS sample buffer with or without
reducing agent at room temperature for 10 mins, sepa-
rated by SDS-PAGE, and detected by Western blotting
(Fig. 9). Reduced MOMP appeared as a single band of ~38
kDa, but non-reduced MOMP occupied several distinct
bands. SDS-denatured, monomeric MOMP appeared as a
band of ~38 kDa (labeled "denatured monomer"), corre-
sponding to the reduced sample. However, monomeric
MOMP also formed a band of ~35 kDa, running "ahead"
of its normal apparent molecular mass, as previously seen
with "folded" porin monomers [41,42]. Additional,
fainter bands at higher molecular masses corresponded to
dimers, tetramers and possible trimers (~80 kDa, ~160
kDa and ~120 kDa, respectively), similar to the findings
following GE chromatography, with an upper band of
aggregated protein that failed to enter the gel.
Surface-expressed MOMP is functional
Fully processed and correctly folded MOMP should func-
tion as a porin-like ion channel [6]. We tested this crucial
prediction by expressing "wild-type" full-length recom-
binant C. trachomatis MOMP in BL21omp8 cells which
express only a small subset of native E. coli porins, and not
OmpF or OmpC [34]. We then functionally reconstituted
solubilised BL21omp8 OM protein GE fractions in
voltage-clamped planar lipid bilayers. Fractions contain-
ing "oligomeric" MOMP complexes gave rise to large-con-
ductance, porin-like ion channels (Fig. 10). Similar
channels were recorded irrespective of whether the deter-
gent was LDAO or Zwittergent 3–14 (using fractions cor-
responding to 195 ml or 180 ml, respectively). The
channels were voltage-dependent, closing at relatively
high holding potentials (e.g. + or - 100 mV), but
Loop and strand deletion maps Figure 6
Loop and strand deletion maps. A. Summary of individual loop deletions (filled residues) providing four C. trachomatis 
MOMP proteins deficient in VS domains 1, 2, 3 or 4 (designated ∆VS1-4, respectively). B. Deletion of predicted β-strand 5 and 
its associated internal loop, designated in the text as ∆β5. C Deletion of predicted β-strands 5 and 6 and their associated inter-
nal and external loops, designated in the text as ∆β5,6.
A B
C
VS1
VS2
VS3
VS4
loop deletions (summary) strand deletionsBMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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remaining open around 0 mV. The single-channel con-
ductance in symmetric 500 mM KCl was 480 ± 19 pS
(mean ± SEM, n = 6 independent experiments), and the
reversal potential in 500 mM vs 50 mM KCl (cis vs trans)
was -31 ± 1.5 mV (mean ± SEM, n = 9 independent exper-
iments). This corresponded to a relative cation vs anion
selectivity of 3.8 under these specific ionic conditions.
Control preparations (detailed under Methods), includ-
ing membrane proteins from control BL21omp8 cells
subjected to the same experimental conditions, where
OM proteins were solubilised and subjected to GE chro-
matography in exactly the same way, did not give rise to
similar channel activity (6 experiments).
Discussion
Functional reconstitution of recombinant C. trachomatis
MOMP at the single-channel (single molecule) level from
cells lacking many endogenous porins provides very
strong evidence that MOMP adopted its native fold when
expressed in E. coli under suitable conditions. Although a
leadered version of recombinant chlamydial MOMP was
expressed and functionally analysed previously [27],
Effects of cysteine mutagenesis and loop and strand deletions  on surface exposure of MOMP Figure 7
Effects of cysteine mutagenesis and loop and strand 
deletions on surface exposure of MOMP. A. Replace-
ment of all 9 cysteine residues in C. trachomatis MOMP by 
alanine residues fails to prevent surface exposure. BL: non-
expressing BL21 cells; mature: cells expressing mature 
MOMP without a leader sequence; oT-leader and n-leader, 
cells expressing MOMPs with ompT and native leaders, 
respectively. B. Removal of loops containing putative external 
VS domains (shown in Fig. 6A) fails to prevent surface expo-
sure. TR: cells expressing mature MOMP; nL-TR: unmodified 
MOMP with its native leader. C. Removal of putative β-
strand regions illustrated in Fig. 6B–C prevents surface expo-
sure. Each result is representative of at least 3 similar 
experiments.
Gel-exclusion chromatography of solubilised MOMPs Figure 8
Gel-exclusion chromatography of solubilised 
MOMPs. A. GE analysis of C. trachomatis MOMP expressed 
in BL21omp8 cells with the OmpT leader, solubilised from an 
OM preparation in 1% (w/v) LDAO. Immuno-dotblots from 
successive 5 ml fractions between 100–220 ml (shown below 
the absorbance trace) reveal the appearance of high-molecu-
lar mass MOMP aggregates after the void volume, with a sec-
ond immunoreactive peak at 195 ml (range 185–205 ml), 
corresponding to a molecular mass of 80 kDa (note inset col-
umn calibration trace, also in the presence of detergent). B. 
GE analysis of C. trachomatis MOMP expressed as in A but 
solubilised in 1% (w/v) Zwittergent 3–14. Oligomeric MOMP 
peaks at 180 ml (range 170–190 ml), corresponding to a 
molecular mass of 120 kDa. C. GE analysis of C. trachomatis 
MOMP in which all 9 cysteines were changed to alanine, 
expressed and solubilised as in B. Oligomeric MOMP peaks 
at 170 ml (range 160–190 ml), corresponding to a molecular 
mass of 160 kDa. Each trace is representative of at least 3 
experiments.BMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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membranes containing the protein were co-reconstituted
with endogenous E. coli porins for liposome-swelling
studies. Although MOMP may have contributed addi-
tional porin-like activity, functional modification of
endogenous porins could not be ruled out.
Interestingly, the successful expression and processing of
recombinant chlamydial porins in E. coli cells depends on
the precise leader sequence, as well as on the specific pro-
tein. PorB is less "toxic" with its native leader, in contrast
to MOMP, which is less "toxic" with the E. coli OmpT
leader, and native-leadered C. muridarum MOMP is less
deleterious to E. coli than Ch. abortus MOMP. Although a
full investigation of the role of leader sequences could not
be undertaken here, it is known that successful OM inser-
tion, as well as prior transport across the inner membrane
and processing, is also signal sequence-dependent. For
example, a large proportion of E. coli LamB porins with
signal sequence mutations remained "tethered" to the
inner membrane (probably by their unprocessed signal
sequence), even though the protein was also closely asso-
ciated with the OM [43]. For C. trachomatis MOMP, use of
the Omp-T leader and induction at 16°C (not induction
at 37°C, as previously employed), in either "wild-type"
cells or "porin knockout" cells in a supportive medium
(SOC), provides improved processing and OM insertion,
and there is also significant insertion at 25°C in "wild-
type" E. coli.
The single-channel properties of C. trachomatis MOMP are
consistent with previous data on bacterial [40] and puta-
tive chlamydial [6] porins. In particular, the channels
show "bell-shaped" voltage-dependent gating and are
mainly open around ~0 mV, with very high conductances
(close to the saturating conductances predicted for a large
water-filled pore) and poor ionic selectivity, showing only
a slight preference (~4:1) for cations over anions (using a
Nernst-Plank analysis because relatively wide, water-filled
porin channels are probably electroneutral [35], and
poorly-described by electrodiffusion theory). The chan-
nels often appeared in groups of three, as might be
expected for a trimeric "triple-barrelled" porin (e.g. Fig.
10). However, unless the channels were randomly incor-
porated into the bilayer (which is difficult to demon-
strate), these complexes may represent a selected sub-
population.
Despite the lack of sequence similarity to known bacterial
porins, a combination of different predictive approaches
(none of which was entirely satisfactory in isolation), set
in the context of elegant and pioneering work from many
laboratories on the properties of VS domains, predicted
that  C. trachomatis MOMP, like putative porins in the
intracellular pathogens Burkholderia thailandensis and B.
pseudomallei [44], could be a 16-stranded β-barrel. Our
working model pays due attention to the construction
principles for β-barrels [39,40]. The N and C termini com-
plete final strand 16, the periplasmic turns are short, and
most external loops are long and include the immuno-
genic VS domains. The barrel surface in contact with the
bilayer consists largely (though not exclusively) of hydro-
phobic side chains, and all 18 strand residues with
charged side chains project into the pore to line the central
water-filled central channel. 6 cysteines lie in extracellular
loops, and 2 periplasmic cysteines lie on opposite sides of
the barrel where they are unlikely to form an intrasubunit
disulphide bond, although they could form intersubunit
bonds, or bonds with other proteins. A single membrane
thiol projects into the barrel pore, where it could be
involved in disulphide bond formation if a loop (e.g. L1)
were to fold into the barrel.
Our working model for the membrane topology of C. tra-
chomatis MOMP differs in some significant respects from
Cysteine cross-linking of recombinant C. trachomatis MOMP Figure 9
Cysteine cross-linking of recombinant C. trachomatis 
MOMP. MOMP expressed in BL21omp8 cells with the 
OmpT leader was covalently cross-linked as described in the 
text and OM proteins were separated by reducing (RED) and 
non-reducing (OX) SDS-PAGE, followed by Western blot-
ting using a specific anti-MOMP antibody. The positions of 
molecular mass markers are shown to the left, and the pro-
posed identities of bands are shown to the right.
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the recent prediction for C. muridarum MOMP [45]
(which was based partly on hydrophobicity plots).
Although both studies predict that MOMPs are 16-
stranded β-barrels with an average strand length of ~8 res-
idues, periplasmic thiols are absent from the C. muridarum
prediction. This would preclude the significant
interactions with OmcB and OmcA, described in the Back-
ground. We also assigned L2, 4, 6 and 7 as C. trachomatis
VS domains, not L2, 3, 5 and 6, the homologous regions
in C. muridarum MOMP. Experimental tests of the pre-
dicted membrane topology of C. trachomatis MOMP are
consistent with our model, because individual VS
domains can be substantially truncated without prevent-
ing incorporation of the protein into the bacterial OM. If
MOMP is a β-barrel porin, as suggested, and VS domains
are confined to specific extracellular loops, it is conceiva-
ble that MOMP can continue to fold into a β-barrel in the
absence of one of these domains. On the other hand, the
removal of β-strands would disrupt folding. Removal of a
single strand, bringing periplasmic residues into direct
contact with external residues, is predicted to be particu-
larly destructive to the global fold. Removal of more than
one strand might be better tolerated, provided the β-barrel
can form with a significantly reduced diameter. In prac-
tice, it appears that C. trachomatis MOMP cannot accom-
modate either type of strand modification.
Single-channel analysis of recombinant C. trachomatis MOMP from BL21omp8 cells Figure 10
Single-channel analysis of recombinant C. trachomatis MOMP from BL21omp8 cells. A. Channel currents in 
response to two transmembrane voltage ramps (-100 mV to +100 mV), with 1 M KCl cis and trans. Up to 3 channels are open 
during ramp (a), and 2 of the channels close in succession at about +80 mV. In ramp (b), 1 channel is open at 0 mV, and 2 chan-
nels are open at +100 mV. B. Channel currents in the presence of 500 mM KCl cis and trans during two voltage ramps (as in A). 
Note the reduction in single-current amplitudes, and current reversal at 0 mV as in A. C. Currents during two voltage ramps in 
asymmetric KCl, 500 mM cis vs 50 mM trans. Note the shift in equilibrium potential (Er) from 0 mV to -30 mV (arrowed). Posi-
tive (upgoing) currents at 0 mV indicate a net flux of K+ cis to trans in the absence of an electrical driving force. D. Equilibrium 
currents in symmetric 500 mM KCl at a constant holding potential of +100 mV, showing brief single-channel closures and volt-
age-dependent inactivation of all 3 channels within 5 s.
time (s)
+100 mV
+100 mV
+100 mV
-100 mV
-100 mV
-100 mV
+100 mV
A
D C
B
0 1             2             3             4 5
500 pA
a
bBMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
Page 12 of 15
(page number not for citation purposes)
GE chromatography suggested that MOMP forms oligom-
ers in the presence of Zwittergent or LDAO, and in line
with these findings, in situ cysteine cross-linking of recom-
binant MOMP in E. coli OMs revealed oligomeric MOMP
complexes, together with a species of folded or partially-
folded MOMP monomers containing at least one
intramolecular disulphide bond. This species contrasts
with reduced, denatured MOMP monomers seen when
chlamydial MOMP is solubilised directly from OMs (or
native EBs [6]). However, the exact stoichiometry of
MOMP oligomers in the E. coli OM remains uncertain
because our size estimates for the oligomers, and thus
their stoichiometries, may be too high because of uncor-
rected bound detergent. Also, it is clear that the stability of
MOMP oligomers is detergent-dependent.
Native Ch. abortus MOMP forms SDS-resistant oligomers
of ~100 K [6], unlike the SDS-unstable MOMP oligomers
isolated from E. coli OMs. We speculate that this may be
because native MOMP oligomers are stabilised by interac-
tions with other chlamydial components (e.g. co-purified
Omp90 [6]), and possibly also by disulphide bonds.
Disulphide bond formation (whether transient or perma-
nent) does not appear to be essential during protein fold-
ing and OM insertion, because a cysteine-free mutant can
be fully processed (Fig. 7A) and can also form oligomers.
Overall, our results show that the subunit stoichiometry
of detergent-solubilised MOMPs expressed and processed
in E. coli is detergent-dependent, that MOMP subunits can
be cross-linked by disulphide bridges, and that folded
monomers contain at least one intrasubunit disulphide
bond (Fig. 8).
Conclusions
C. trachomatis MOMP, an immunodominant, cysteine-
rich, chlamydial surface protein of crucial importance in
the immune response to infection, is a major subunit vac-
cine target. However, unlike many other bacterial porins,
it has been difficult to refold from inclusion bodies or to
achieve and demonstrate functional surface expression.
This study is the first to report unambiguous functional
analysis, by single-channel recording, of recombinant
chlamydial MOMP recovered from bacterial outer mem-
branes. The modified expression system described in the
present study provided a means to test specific hypotheses
provided by a working model for the C. trachomatis pro-
tein. However, although our results are consistent with a
working model of MOMP as a 16-stranded β-barrel, more
mutations or other approaches are needed before a spe-
cific model can be accepted. The protein also formed oli-
gomers, even in the complete absence of cysteine residues.
The surface display of modified, functional MOMP in E.
coli cells (potential vehicles for a live, subunit vaccine),
together with a working topological model, could guide
the removal of unwanted or harmful epitopes from engi-
neered proteins, and it might also be possible to display
external loops containing specific MOMP epitopes on
other porin "scaffolds" in living cells. However, it is
important to note that such approaches will be limited if
essential disulphide bonds in the native chlamydial enve-
lope, including bonds involving non-MOMP cysteines,
stabilise the conformation of key immunogenic VS
domains.
Methods
DNA manipulations
C. trachomatis ompA (corresponding to X62918, from the
Da serovar) and Ch. abortus ompA were cloned without
their leader sequences into the Nde-I/Nco-I sites of
pET22b(+) (Novagen) after destroying an internal Nde-I
site in C. trachomatis ompA by Quik-Change PCR mutagen-
esis (Stratagene). This did not alter the encoded protein.
C. muridarum ompA and porB were amplified with and
without their leaders from genomic DNA and cloned into
the Nde-I/Bam-HI sites and Nde-I/Nco-I sites, respectively,
of the same vector (C. muridarum ompA also required null
mutation removal of an internal Nde-I site). The E. coli
OmpT protease leader sequence or the native C. trachom-
atis MOMP leader sequence was added to the 5' end of the
leaderless C. trachomatis and Ch. abortus inserts by sequen-
tial gene extension PCR using three overlapping primers.
A 5' Nde-I site was again used to provide the starting
methionine codon in the final full-length construct. Quik-
Change PCR was also used to create pairs of unique inter-
nal restriction sites in native-leadered C. trachomatis ompA
to permit the deletion of specific domains by plasmid
restriction and religation [33]. These sites were: for VS1,
Age-I; for VS2, Bcl-I; and for VS3, VS4 and the predicted β-
strands,  Aat-II. Successful deletions were confirmed by
hemi-nested single-colony PCR (using Taq polymerase) to
identify clones that could be amplified by gene-spanning
primers but not by primers complementary to regions that
had been removed. We also generated C. trachomatis
MOMP expression constructs containing inserts in which
all 9 cysteine residues (C26, C29, C33, C102, C115, C182,
C184, C207 and C335) were replaced by alanine using
Quik-Change PCR. Most of the modifications were carried
out in a pSTBlue-I/NovaBlue system, and the fidelity of
each insert was confirmed by automated DNA sequencing
(MWG Biotech).
Protein expression and recovery
E. coli BL21(DE3) or BL21(DE3)omp8 [34] cells were har-
vested from cultures of LB (Luria-Bertani) medium (10 g/
l Bacto tryptone, 5 g/l yeast extract, 10 g/l NaCl, pH 7.0)
or SOC medium (20 g/l Bacto tryptone, 5 g/l yeast extract,
0.5 g/l NaCl, 20 mM glucose, pH 7.0) by centrifugation at
6,000 × g for 5 mins after inductions as described in the
Results section, and washed in 50 ml phosphate buffered
saline (PBS). The cell pellet was resuspended in 5 ml TENBMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 100 mM
NaCl) containing 1 mg lysozyme and incubated for 30
min. at room temperature. Following sonication (6 × 15
s, 6 µm amplitude, Sanyo Soniprep 150 sonicator) the cell
lysate was incubated with 20 U/ml Benzonase (Novagen)
for 15 min at room temperature. OM fragments were pel-
leted by centrifugation at 15,000 × g for 10 min, and
washed twice in 20 ml TEN buffer. Membrane proteins
were solubilised by resuspending the pellet in 6 ml
solubilisation buffer containing 50 mM Tris-HCl, pH 8.0,
1 mM EDTA, 50 mM NaCl and 10 mM DTT with either
1% (w/v) octyl glucoside (OG, Anatrace), 1% (w/v) lauryl
(dodecyl) dimethylamine oxide (L(D)DAO, Anatrace) or
1% (w/v) Zwittergent 3–14 (Anzergent 3–14, Anatrace),
and incubating at 37°C for 1 hour. The solution was clar-
ified by ultracentrifugation (Beckman TLA-100) for 20
mins at 100,000 rpm. Protein concentrations were deter-
mined after TCA precipitation.
SDS-PAGE and Western blotting
Unless otherwise indicated, SDS-PAGE was carried out
under reducing conditions using 10–12% (w/v) gels.
Molecular masses were estimated from plots of relative
mobility vs the logarithm of the molecular mass of Preci-
sion Plus unstained protein markers (BioRad). For West-
ern blotting, proteins were electrophoretically transferred
to PVDF membranes under conditions compatible with
the transfer of high-MW proteins including native MOMP
oligomers [6]. The membranes were blocked in 5% (w/v)
non-fat milk in PBS-T (0.005% (v/v) Tween-20 in PBS)
then incubated in 1:5000 goat anti-C. trachomatis MOMP
antibody (Fitzgerald International) for 1 hour at room
temperature. Following 2 × 30 sec and 3 × 5 min washes
in PBS-T, membranes were incubated in 1:10,000 HRP-
conjugated anti-goat/sheep antibody (Sigma) for 1 hr at
room temperature. After washing, immunoreactive pro-
teins were detected by ECL.
Whole cell immunoblotting and immunofluorescence
10 ml of LB medium was seeded 1:100 with cultures
grown to saturation overnight, and incubated until the
OD reached 0.6. The cells were pelleted by centrifugation
(6,000 g × 10 mins) and resuspended in fresh medium.
Following incubation at the selected temperature for 10
mins, 0.1–1 mM IPTG was added and incubation was
continued for another 2–16 hrs. Intact cells were
harvested by gentle centrifugation (4,500 g × 5 mins) and
washed in 1 ml PBS. The pellets were resuspended in 200
µl PBS, and 10 µl was applied to a nitrocellulose mem-
brane and allowed to dry. The membrane was blocked
and probed with anti-C. trachomatis MOMP polyclonal
antibody as described above. Immunofluorescence was
carried out as described previously [26], with fixation and
permeabilisation either before or after immunostaining,
using 1:200 dilutions of the above primary antibody and
fluorescein-conjugated anti-goat secondary antibody
(Sigma). The cells were then observed by bright field,
phase contrast and fluorescence microscopy using a Leica
TCS-NT confocal microscope.
Gel-exclusion chromatography
Solublised OM proteins were separated by GE chromatog-
raphy using a high resolution 26/60 HiLoad Superdex 200
prep grade column (Amersham Pharmacia Biotech)
freshly equilibrated in 50 mM Tris-HCl (pH 8.0), 1 mM
EDTA, 50 mM NaCl and 5 mM DTT (omitting the latter
for the cysteine-less MOMP mutant). The buffer also con-
tained either 0.05% (w/v) LDAO or 0.05% (w/v) Zwitter-
gent 3–14. 2 ml aliquots of solubilised OM proteins
(containing up to 10 mg protein, solubilised as described
earlier under protein expression) were loaded, and the
column was eluted with the same buffer for 800 min. at a
flow rate of 0.5 ml/min. 5 ml fractions were collected and
10 µl of each protein-containing fraction was deposited
onto a pre-prepared PVDF membrane and probed for
MOMP as described earlier under Western blotting. The
column (Vt 320 ml) was calibrated in the presence of
detergent using standard proteins. V0 (the void volume)
was 115 ml, and Kav was calculated as (Ve - V0)/(Vt - V0),
where Ve is the elution volume.
Bilayer reconstitution and single-channel analysis
Planar bilayers were cast from diphytanoyl phosphatidyl-
choline (Avanti) between two 0.5 ml chambers contain-
ing 50 mM KCl, 20 mM Tris-HCl (pH 8.0) and 1 mM DTT,
designated cis and trans [6]. The cis chamber was voltage
clamped with respect to the trans chamber using an Axon
200B amplifier or a Biologic RK300 amplifier. 1–5 µl aliq-
uots of pre-diluted solubilised proteins (containing up to
10 ng protein and no more than 5 ng detergent) were
added to the cis chamber, followed by aliquots of 5 M KCl
to raise the salt concentration to 500 mM. Channel incor-
poration usually occurred within 30 min, accelerated by
switching the holding potential between +/- 60 mV.
Experimental protocols were programmed and the digi-
tised data were low-pass filtered (1 kHz, 8-pole Bessel-
type response) and recorded using pClamp8 software
(Axon Instruments), and analysed offline. The bilayer
potential was slowly and repeatedly ramped between -100
mV and +100 mV (each sweep taking 32 s) in the presence
of an asymmetric (500 mM vs 50 mM, cis vs trans) gradient
of KCl, or with equimolar 500 mM or 1 M KCl. At least 3
voltage ramps were recorded and analysed for each exper-
iment, and equilibrium recordings were obtained at
defined holding potentials. Holding potentials refer to the
cis chamber, and upgoing deflections represent net move-
ment of cations from cis to trans or of anions from trans to
cis. Relative ionic permeabilities were determined from
the equilibrium solution of the Nernst-Planck flux equa-
tions [35]. When the cation and anion fluxes are equal:BMC Microbiology 2005, 5:5 http://www.biomedcentral.com/1471-2180/5/5
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Er is the equilibrium (zero current, or reversal) potential in
asymmetric KCl, and R, T and F have their usual signifi-
cance.   (the permeability ratio of K+ to Cl-) was
calculated using appropriate activity coefficients (a) from
standard tables. Control experiments were carried out
using equivalent amounts of detergent and with equiva-
lent amounts of solubilised OM proteins purified from
non-transformed bacteria, selecting identical GE column
fractions.
Membrane topology prediction
The number of membrane crossings was predicted using a
neural network based-outer membrane protein topology
prediction program trained with known porins [36]. We
discounted a predicted membrane crossing very near the
N-terminus that was only apparent after numerical round-
ing. β-strands were predicted independently by similar
computational approaches using B2TMPRED [37] and
TMBETA [38], respectively. The three predictions were
combined and adjusted manually, taking account of the
accessibility of the VS domains of C. trachomatis MOMP
and the known characteristics of antiparallel, amphip-
athic β-barrel strands in porins.
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